FDA rejects Replimune’s oncolytic virus therapy for advanced melanomanews2025-07-22T12:07:52+00:00July 22nd, 2025|Endpoints News|
Scancell’s skin cancer vaccines show Phase 2 promise but only one set to advancenews2025-07-22T11:43:38+00:00July 22nd, 2025|Endpoints News|
Circular RNA startup Orbital unveils first monkey data as it enters in vivo CAR-T cell therapy racenews2025-07-22T10:00:54+00:00July 22nd, 2025|Endpoints News|
Endpoints livestream: What happens next with Sarepta’s Duchenne crisis? news2025-07-21T15:14:09+00:00July 21st, 2025|Endpoints News|
Roche’s IL-33 antibody misses in COPD after Sanofi and Regeneron’s drug fell shortnews2025-07-21T14:14:09+00:00July 21st, 2025|Endpoints News|
Alkermes gets a mid-stage narcolepsy hit, but trails Takeda in R&D racenews2025-07-21T10:07:25+00:00July 21st, 2025|Endpoints News|
The FDA’s new SSRI experts have long questioned antidepressant usenews2025-07-21T10:00:41+00:00July 21st, 2025|Endpoints News|
Sarepta says it won’t pull Duchenne gene therapy, setting up showdown with FDAnews2025-07-19T00:43:48+00:00July 19th, 2025|Endpoints News|
Sail Bio cuts staff by 30% and trims leadership teamnews2025-07-18T19:43:18+00:00July 18th, 2025|Endpoints News|
David Baker’s lab uses AI to help catch nature’s squirmiest proteinsnews2025-07-18T15:27:46+00:00July 18th, 2025|Endpoints News|
